Skip to main content

Rossmore Private Capital

Position in NVO — Novo Nordisk A S

CIK 1733082 GLASTONBURY, CT

Position in NVO

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$1,102,620
+$257,370 QoQ
Shares Held
23,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#508
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Rossmore Private Capital holds $82,109,326 across 11 Drug Manufacturers - General names. NVO ranks #7 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
23,000 $1,102,620

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,102,620 23,000
2026-03-31 $845,250 23,000
2025-12-31 $1,205,856 23,700
2025-09-30 $1,276,270 23,000
2025-06-30 $1,587,460 23,000
2025-03-31 $1,618,299 23,305
2024-12-31 $1,995,061 23,193
2024-09-30 $2,757,065 23,155
2024-06-30 $3,283,020 23,000
2024-03-31 $2,953,200 23,000
2023-12-31 $2,379,350 23,000
2023-09-30 $2,091,620 23,000
2023-06-30 $1,861,045 11,500
2023-03-31 $1,830,110 11,500
2022-12-31 $1,556,410 11,500
2022-09-30 $1,145,745 11,500
2022-06-30 $1,281,445 11,500
2022-03-31 $1,277,075 11,500
2021-12-31 $1,288,000 11,500
2021-09-30 $1,104,115 11,500
2021-06-30 $963,355 11,500
2021-03-31 $775,330 11,500
2020-12-31 $803,275 11,500
2020-09-30 $798,445 11,500
2020-06-30 $753,020 11,500
2020-03-31 $692,300 11,500